Eculizumab for Atypical Hemolytic-Uremic Syndrome.

被引:277
|
作者
Nuernberger, Jens [1 ]
Witzke, Oliver [1 ]
Saez, Anabelle Opazo [1 ]
Vester, Udo [1 ]
Baba, Hideo Andreas [1 ]
Kribben, Andreas [1 ]
Zimmerhackl, Lothar Bernd [2 ]
Janecke, Andreas R. [2 ]
Nagel, Mato [3 ]
Kirschfink, Michael [4 ]
机构
[1] Univ Duisburg Essen, D-45122 Essen, Germany
[2] Innsbruck Med Univ, A-6020 Innsbruck, Austria
[3] Ctr Nephrol & Metab Disorders, D-02943 Weisswasser, Germany
[4] Univ Heidelberg, D-69120 Heidelberg, Germany
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 05期
关键词
D O I
10.1056/NEJMc0808527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:542 / 544
页数:3
相关论文
共 50 条
  • [31] Pharmacological treatment of atypical hemolytic-uremic syndrome
    Vester, Udo
    Mache, Christoph J.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (02): : 123 - 135
  • [32] MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
    Noris, Marina
    Remuzzi, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (17): : 1676 - 1687
  • [33] SUCCESSFUL TREATMENT OF RECURRENT ATYPICAL HEMOLYTIC-UREMIC SYNDROME WITH ECULIZUMAB AFTER PEDIATRIC KIDNEY TRANSPLANTATION
    Somers, Michael J. G.
    Rodig, Nancy M.
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 82 - 82
  • [34] Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
    Mache, Christoph J.
    Acham-Roschitz, Birgit
    Fremeaux-Bacchi, Veronique
    Kirschfink, Michael
    Zipfel, Peter F.
    Roedl, Siegfried
    Vester, Udo
    Ring, Ekkehard
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08): : 1312 - 1316
  • [35] SUCCESS OF ECULIZUMAB IN THE TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Kantar, Asli
    Gulleroglu, Kaan
    Bayrakci, Umut
    Ozkaya, Ozan
    Ozcan, Ebru
    Baskin, Esra
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1572 - 1572
  • [36] The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
    Santos, Mariana S.
    Ventura, Sofia
    Alves, Abel
    Cabral, Raquel
    Henriques, Manuela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [37] Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome
    ter Avest, Mendy
    Steenbreker, Hilbert
    Bouwmeester, Romy N.
    Duineveld, Caroline
    Wijnsma, Kioa L.
    van den Heuvel, Lambertus P. W. J.
    Langemeijer, Saskia M. C.
    Wetzels, Jack F. M.
    van de Kar, Nicole C. A. J.
    ter Heine, Rob
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (06): : 759 - 766
  • [38] THE EFFICACY OF ECULIZUMAB IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Matsumura, D.
    Sato, E.
    Lu, H.
    Nomura, M.
    Amaha, M.
    Fujii, A.
    Ono, Y.
    Ueda, Y.
    Nakamura, T.
    NEPHROLOGY, 2016, 21 : 267 - 267
  • [39] Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
    Palma, Lilian M. Pereira
    Langman, Craig B.
    JOURNAL OF BLOOD MEDICINE, 2016, 7 : 39 - 72
  • [40] Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants
    Ariceta, Gema
    Arrizabalaga, Beatriz
    Aguirre, Mireia
    Morteruel, Elvira
    Lopez-Trascasa, Margarita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (05) : 707 - 710